{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:16Z","timestamp":1786980136745,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00415-020-10332-5","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T15:02:39Z","timestamp":1609599759000},"page":"1792-1802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study"],"prefix":"10.1007","volume":"268","author":[{"given":"Giorgia","family":"Querin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Debs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Behin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Salachas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Le Forestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Del Mar","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Bruneteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Blancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Marchand-Pauvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Hogrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"10332_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"issue":"2","key":"10332_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"1992","author":"TL Munsat","year":"1992","unstructured":"Munsat TL, Davies KE (1992) International SMA consortium meeting (26-28 June 1992, Bonn, Germany). Neuromuscul Disord NMD 1992(2):423\u2013428","journal-title":"Neuromuscul Disord NMD"},{"key":"10332_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ene.13534","volume":"25","author":"RI Wadman","year":"2018","unstructured":"Wadman RI, Wijngaarde CA, Stam M et al (2018) Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c\u20134. Eur J Neurol 25:512\u2013518","journal-title":"Eur J Neurol"},{"key":"10332_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES et al (2007) Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 22:1027\u20131049","journal-title":"J Child Neurol"},{"key":"10332_CR5","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1212\/WNL.0000000000008166","volume":"93","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, Lucibello S, Pera MC et al (2019) Long-term progression in type II spinal muscular atrophy: a retrospective observational study. Neurology 93:e1241\u2013e1247","journal-title":"Neurology"},{"key":"10332_CR6","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","volume":"255","author":"S Piepers","year":"2008","unstructured":"Piepers S, van den Berg LH, Brugman F et al (2008) A natural history study of late onset spinal muscular atrophy types 3b and 4. J Neurol 255:1400\u20131404","journal-title":"J Neurol"},{"key":"10332_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1212\/01.wnl.0000324623.89105.c4","volume":"71","author":"F Deymeer","year":"2008","unstructured":"Deymeer F, Serdaroglu P, Parman Y, Poda M (2008) Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude. Neurology 71:644\u2013649","journal-title":"Neurology"},{"key":"10332_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/acn3.406","volume":"4","author":"U Bonati","year":"2017","unstructured":"Bonati U, Holiga \u0160, Hellbach N et al (2017) Longitudinal characterization of biomarkers for spinal muscular atrophy. Ann Clin Transl Neurol 4:292\u2013304","journal-title":"Ann Clin Transl Neurol"},{"key":"10332_CR9","doi-asserted-by":"publisher","first-page":"e0199657","DOI":"10.1371\/journal.pone.0199657","volume":"13","author":"J Montes","year":"2018","unstructured":"Montes J, McDermott MP, Mirek E et al (2018) Ambulatory function in spinal muscular atrophy: age-related patterns of progression. PLoS ONE 13:e0199657","journal-title":"PLoS ONE"},{"key":"10332_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA et al (2018) Nusinersen versus Sham control in later-onset spinal muscular atrophy. N Engl J Med 378:625\u2013635","journal-title":"N Engl J Med"},{"key":"10332_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R et al (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377:1713\u20131722","journal-title":"N Engl J Med"},{"key":"10332_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/0883073809332702","volume":"24","author":"J Montes","year":"2009","unstructured":"Montes J, Gordon AM, Pandya S, De Vivo DC, Kaufmann P (2009) Clinical outcome measures in spinal muscular atrophy. J Child Neurol 24:968\u2013978","journal-title":"J Child Neurol"},{"key":"10332_CR13","doi-asserted-by":"crossref","unstructured":"Finkel R, Bertini E, Muntoni F, Mercuri E, ENMC SMA Workshop Study Group (2014) 209th ENMC International Workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7\u20139 November 2014, Heemskerk, The Netherlands. In: Neuromuscular disorder, vol 25. Elsevier, The Netherlands, pp 593\u2013602","DOI":"10.1016\/j.nmd.2015.04.009"},{"key":"10332_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fneur.2019.00898","volume":"10","author":"DST Kariyawasam","year":"2019","unstructured":"Kariyawasam DST, D\u2019Silva A, Lin C, Ryan MM, Farrar MA (2019) Biomarkers and the development of a personalized medicine approach in spinal muscular atrophy. Front Neurol 10:898","journal-title":"Front Neurol"},{"key":"10332_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/mus.24670","volume":"52","author":"J Montes","year":"2015","unstructured":"Montes J, Glanzman AM, Mazzone ES et al (2015) Spinal muscular atrophy functional composite score: a functional measure in spinal muscular atrophy. Muscle Nerve 52:942\u2013947","journal-title":"Muscle Nerve"},{"key":"10332_CR16","doi-asserted-by":"publisher","first-page":"e0121799","DOI":"10.1371\/journal.pone.0121799","volume":"10","author":"AM Seferian","year":"2015","unstructured":"Seferian AM, Moraux A, Canal A et al (2015) Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial. PLoS ONE 10:e0121799","journal-title":"PLoS ONE"},{"key":"10332_CR17","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1109\/TBME.2004.834281","volume":"51","author":"SD Nandedkar","year":"2004","unstructured":"Nandedkar SD, Nandedkar DS, Barkhaus PE, Stalberg EV (2004) Motor unit number index (MUNIX). IEEE Trans Biomed Eng 51:2209\u20132211","journal-title":"IEEE Trans Biomed Eng"},{"key":"10332_CR18","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.clinph.2018.08.025","volume":"129","author":"G Querin","year":"2018","unstructured":"Querin G, Lenglet T, Debs R et al (2018) The motor unit number index (MUNIX) profile of patients with adult spinal muscular atrophy. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 129:2333\u20132340","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10332_CR19","doi-asserted-by":"publisher","first-page":"101618","DOI":"10.1016\/j.nicl.2018.101618","volume":"21","author":"G Querin","year":"2018","unstructured":"Querin G, El Mendili M-M, Lenglet T et al (2018) The spinal and cerebral profile of adult spinal-muscular atrophy: a multimodal imaging study. NeuroImage Clin 21:101618","journal-title":"NeuroImage Clin"},{"key":"10332_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F et al (2018) Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103\u2013115","journal-title":"Neuromuscul Disord"},{"key":"10332_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/mus.25120","volume":"54","author":"S Dunaway Young","year":"2016","unstructured":"Dunaway Young S, Montes J, Kramer SS et al (2016) Six-minute walk test is reliable and valid in spinal muscular atrophy. Muscle Nerve 54:836\u2013842","journal-title":"Muscle Nerve"},{"key":"10332_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/mus.26633","volume":"60","author":"J Montes","year":"2019","unstructured":"Montes J, Dunaway Young S, Mazzone ES et al (2019) Nusinersen improves walking distance and reduces fatigue in later-onset SMA. Muscle Nerve 60:409\u2013414","journal-title":"Muscle Nerve"},{"key":"10332_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.apmr.2013.01.014","volume":"94","author":"C Vuillerot","year":"2013","unstructured":"Vuillerot C, Payan C, Iwaz J, Ecochard R, B\u00e9rard C (2013) MFM spinal muscular atrophy study group. responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil 94:1555\u20131561","journal-title":"Arch Phys Med Rehabil"},{"key":"10332_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(17)30085-6","volume":"16","author":"E Bertini","year":"2017","unstructured":"Bertini E, Dessaud E, Mercuri E et al (2017) Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 16:513\u2013522","journal-title":"Lancet Neurol"},{"key":"10332_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.nmd.2012.05.004","volume":"22","author":"Y Allenbach","year":"2012","unstructured":"Allenbach Y, Benveniste O, Decostre V et al (2012) Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis. Neuromuscul Disord NMD 22:980\u2013986","journal-title":"Neuromuscul Disord NMD"},{"key":"10332_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nmd.2012.10.022","volume":"23","author":"L Servais","year":"2013","unstructured":"Servais L, Deconinck N, Moraux A et al (2013) Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients. Neuromuscul Disord 23:139\u2013148","journal-title":"Neuromuscul Disord"},{"key":"10332_CR27","doi-asserted-by":"publisher","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","volume":"13","author":"A Chabanon","year":"2018","unstructured":"Chabanon A, Seferian AM, Daron A et al (2018) Prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS ONE 13:e0201004","journal-title":"PLoS ONE"},{"key":"10332_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12891-015-0458-9","volume":"16","author":"V Decostre","year":"2015","unstructured":"Decostre V, Canal A, Ollivier G et al (2015) Wrist flexion and extension torques measured by highly sensitive dynamometer in healthy subjects from 5 to 80 years. BMC Musculoskelet Disord 16:4","journal-title":"BMC Musculoskelet Disord"},{"key":"10332_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2474-14-104","volume":"14","author":"A Moraux","year":"2013","unstructured":"Moraux A, Canal A, Ollivier G et al (2013) Ankle dorsi- and plantar-flexion torques measured by dynamometry in healthy subjects from 5 to 80 years. BMC Musculoskelet Disord 14:104","journal-title":"BMC Musculoskelet Disord"},{"key":"10332_CR30","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3174\/ajnr.A5162","volume":"38","author":"AR Martin","year":"2017","unstructured":"Martin AR, De Leener B, Cohen-Adad J et al (2017) A novel MRI biomarker of spinal cord white matter injury: T2*-weighted white matter to gray matter signal intensity ratio. AJNR Am J Neuroradiol 38:1266\u20131273","journal-title":"AJNR Am J Neuroradiol"},{"key":"10332_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroimage.2016.10.009","volume":"145","author":"B De Leener","year":"2017","unstructured":"De Leener B, L\u00e9vy S, Dupont SM et al (2017) SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data. NeuroImage 145:24\u201343","journal-title":"NeuroImage"},{"key":"10332_CR32","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.neuroimage.2018.09.081","volume":"184","author":"C Gros","year":"2019","unstructured":"Gros C, De Leener B, Badji A et al (2019) Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. NeuroImage 184:901\u2013915","journal-title":"NeuroImage"},{"key":"10332_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, Gladman DD (2000) Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53:459\u2013468","journal-title":"J Clin Epidemiol"},{"key":"10332_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00234-019-02189-x","volume":"61","author":"D Oldenburg","year":"2019","unstructured":"Oldenburg D, Guberina N, Stolte B et al (2019) Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy. Neuroradiology Epub 61:565\u2013574","journal-title":"Neuroradiology Epub"},{"key":"10332_CR35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.apmr.2007.07.011","volume":"88","author":"J-Y Hogrel","year":"2007","unstructured":"Hogrel J-Y, Payan CA, Ollivier G et al (2007) Development of a French isometric strength normative database for adults using quantitative muscle testing. Arch Phys Med Rehabil 88:1289\u20131297","journal-title":"Arch Phys Med Rehabil"},{"key":"10332_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0035-3787(06)75033-0","volume":"162","author":"JY Hogrel","year":"2006","unstructured":"Hogrel JY, Ollivier G, Desnuelle C (2006) Manual and quantitative muscle testing in neuromuscular disorders. How to assess the consistency of strength measurements in clinical trials? Rev Neurol 162:427\u2013436","journal-title":"Rev Neurol"},{"key":"10332_CR37","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.clinph.2015.12.023","volume":"127","author":"D Fathi","year":"2016","unstructured":"Fathi D, Mohammadi B, Dengler R, B\u00f6selt S, Petri S, Kollewe K (2016) Lower motor neuron involvement in ALS assessed by motor unit number index (MUNIX): long-term changes and reproducibility. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 127:1984\u20131988","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10332_CR38","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.clinph.2018.04.359","volume":"129","author":"J Bas","year":"2018","unstructured":"Bas J, Delmont E, Fatehi F et al (2018) Motor unit number index correlates with disability in Charcot\u2013Marie-tooth disease. Clin Neurophysiol 129:1390\u20131396","journal-title":"Clin Neurophysiol"},{"key":"10332_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neucli.2018.09.001","volume":"48","author":"F Fatehi","year":"2018","unstructured":"Fatehi F, Grapperon A-M, Fathi D, Delmont E, Attarian S (2018) The utility of motor unit number index: a systematic review. Neurophysiol Clin Clin Neurophysiol 48:251\u2013259","journal-title":"Neurophysiol Clin Clin Neurophysiol"},{"key":"10332_CR40","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.clinph.2011.05.014","volume":"122","author":"C Neuwirth","year":"2011","unstructured":"Neuwirth C, Nandedkar S, St\u00e5lberg E et al (2011) Motor Unit Number Index (MUNIX): reference values of five different muscles in healthy subjects from a multi-centre study. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 122:1895\u20131898","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10332_CR41","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.clinph.2018.04.614","volume":"129","author":"C Neuwirth","year":"2018","unstructured":"Neuwirth C, Braun N, Claeys KG et al (2018) Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: real world experience from 27 centres. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 129:1756\u20131762","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10332_CR42","doi-asserted-by":"publisher","first-page":"e0153948","DOI":"10.1371\/journal.pone.0153948","volume":"11","author":"C Neuwirth","year":"2016","unstructured":"Neuwirth C, Burkhardt C, Alix J et al (2016) Quality control of motor unit number index (MUNIX) measurements in 6 muscles in a single-subject \u201cRound-Robin\u201d setup. PLoS ONE 11:e0153948","journal-title":"PLoS ONE"},{"key":"10332_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fneur.2019.00293","volume":"10","author":"P Lingor","year":"2019","unstructured":"Lingor P, Weber M, Camu W et al (2019) ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the Rho kinase (ROCK) inhibitor Fasudil in amyotrophic lateral sclerosis. Front Neurol 10:293","journal-title":"Front Neurol"},{"key":"10332_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.clinph.2018.11.015","volume":"130","author":"M Swash","year":"2019","unstructured":"Swash M (2019) Reading the palm with MUNIX: a \u201creversed split hand\u201d in spinal muscular atrophy. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 130:305\u2013306","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10332_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.clinph.2018.11.009","volume":"130","author":"R G\u00fcnther","year":"2019","unstructured":"G\u00fcnther R, Neuwirth C, Koch JC et al (2019) Motor Unit Number Index (MUNIX) of hand muscles is a disease biomarker for adult spinal muscular atrophy. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 130:315\u2013319","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10332_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fneur.2019.00229","volume":"10","author":"RH Chipika","year":"2019","unstructured":"Chipika RH, Finegan E, Li Hi Shing S, Hardiman O, Bede P (2019) Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front Neurol 10:229","journal-title":"Front Neurol"},{"key":"10332_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/pst.1701","volume":"14","author":"MC Ard","year":"2015","unstructured":"Ard MC, Raghavan N, Edland SD (2015) Optimal composite scores for longitudinal clinical trials under the linear mixed effects model. Pharm Stat 14:418\u2013426","journal-title":"Pharm Stat"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10332-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T04:15:16Z","timestamp":1674792916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10332-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10332"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10332-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was sponsored by the Association fran\u00e7aise contre les myopathies (AFM-T\u00e9l\u00e9thon). Dr. Giorgia Querin, Dr. Timoth\u00e9e Lenglet, Dr. Rabab Debs, Dr. Tanya Stojkovic, Dr. Anthony Behin, Dr. Fran\u00e7ois Salachas, Dr. Nadine Le Forestier, Dr. Maria del Mar Amador, Dr. Ga\u00eblle Bruneteau, Dr. Sophie Blancho, Dr. V\u00e9ronique Marchand-Pauvert: report no disclosures. Prof Pascal Lafor\u00eat receives funding for research and as an advisor or speaker from Sanofi Genzyme and Spark Therapeutics. Dr. Peter Bede is supported by the Health Research Board (HRB EIA-2017-019), the Andrew Lydon scholarship, the Irish Institute of Clinical Neuroscience (IICN), the Irish Motor Neuron Disease Association (IMNDA) and the Iris O'Brien Foundation. Dr. Jean-Yves Hogrel is co-inventor of the Myogrip and MyoPinch devices and did consultancy for Biogen and Sarepta. Dr Pierre- Fran\u00e7ois Pradat receives funding as an advisor and speaker from Biogen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}